Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.30 | N/A |
| PEG Ratio (TTM) | 7.61 | N/A |
| P/S Ratio (TTM) | 1.67 | N/A |
| P/B Ratio (TTM) | 4.08 | N/A |
| P/FCF Ratio (TTM) | 12.12 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.26 | N/A |
| Price to 5YR AVG FCF Ratio | 12.73 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.93% | N/A |
| ROE (TTM) | 29.23% | N/A |
| Net Profit Margin (TTM) | 13.01% | N/A |
| ROIC 5YR AVG | 13.10% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.34% | 98.01% | 68.50% |
| Revenue | 1.60% | 15.60% | 11.49% |
| Net Income | 3.02% | 98.64% | 66.15% |
| Cash Flow | 0.44% | 76.19% | 43.77% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.82 | N/A |
| Quick Ratio (TTM) | 0.79 | N/A |
| D/E Ratio (TTM) | 1.88 | N/A |
| Interest Coverage (TTM) | 5.38 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.20 | N/A |
| LTL to 5YR AVG FCF | 7.13 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.36% | N/A |